EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

EsophAguS Deviation During RadiofrequencY Ablation of Atrial Fibrillation

Raul Weiss, Jose Osorio, Devi Nair, Luis Aguinaga, Luis Arabia, Diego Alcivar, Amin Al-Ahmad, Gery Tomassoni, Omar Kahaly, Rohit Mehta, Chad Ward, Benjamin Holmes und 10 weitere

JACC: Clinical Electrophysiology · 2024-01 · 10 (1) · 68-78

DOI: 10.1016/j.jacep.2023.09.004 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2024-01. Verfasst von Raul Weiss und 21 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University, Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Radiofrequency Ablation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Injury to the esophagus has been reported in a high percentage of patients undergoing ablation of atrial fibrillation (AF). OBJECTIVES: This study assessed the incidence of esophageal injury in patients undergoing ablation of AF with and without an esophageal deviating device. METHODS: This prospective, randomized, multicenter, double-blinded, controlled Food and Drug Administration investigational device exemption trial compared the incidence of ablation-related esophageal lesions, as assessed by endoscopy, in patients undergoing AF ablation assigned to a control group (luminal esophageal temperature [LET] monitoring alone) compared with patients randomized to a deviation group (esophagus deviation device + LET). This novel deviating device uses vacuum suction and mechanical deflection to deviate a segment of the esophagus, including the trailing edge. RESULTS: The data safety and monitoring board recommended stopping the study early after randomizing 120 patients due to deviating device efficacy. The primary study endpoint, ablation injury to the esophageal mucosa, was significantly less in the deviation group (5.7%) in comparison to the control group (35.4%; P < 0.0001). Control patients had a significantly higher severity and greater number of ablation lesions per patient. There was no adverse event assigned to the device. By multivariable analysis, the only feature associated with reduced esophageal lesions was randomization to deviating device (OR: 0.13; 95% CI: 0.04-0.46; P = 0.001). Among control subjects, there was no difference in esophageal lesions with high power/short duration (31.8%) vs other radiofrequency techniques (37.2%; P = 0.79). CONCLUSIONS: The use of an esophageal deviating device resulted in a significant reduction in ablation-related esophageal lesions without any adverse events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationRadiofrequency AblationHumansProspective StudiesEsophagus

Stichwörter der Autor:innen

atrial fibrillationatrioesophageal fistulacatheter ablationdeviationesophagusradiofrequency

Autor:innen und Institutionen

  • The Ohio State University, Wexner Medical Center, Columbus, Ohio, USA.
  • Alabama Grandview Medical Center, Birmingham, Alabama, USA.
  • Arrhythmia Research Group, Jonesboro, Arkansas, USA.
  • Centro Integral de Arritmias Tucumán, San Miguel de Tucumán, Tucumán, Argentina.
  • Hattiesburg Clinic-Heart & Vascular, Hattiesburg, Missouri, USA.
  • Texas Cardiac Arrhythmia Research Foundation, St. David's Medical Center, Austin, Texas, USA.

Zitieren

APA

Weiss, R., Osorio, J., Nair, D., Aguinaga, L., Arabia, L., Alcivar, D., Al-Ahmad, A., Tomassoni, G., Kahaly, O., Mehta, R., Ward, C., Holmes, B., Patel, D., Killu, A. M., Munger, T., Essandoh, M., Houmsse, M., Rajendra, A., Morales, G., …, & Daoud, E. G. (2024). EsophAguS Deviation During RadiofrequencY Ablation of Atrial Fibrillation. JACC: Clinical Electrophysiology, 10(1), 68-78. https://doi.org/10.1016/j.jacep.2023.09.004

Vancouver

Weiss R, Osorio J, Nair D, Aguinaga L, Arabia L, Alcivar D, et al. EsophAguS Deviation During RadiofrequencY Ablation of Atrial Fibrillation. JACC: Clinical Electrophysiology. 2024;10(1):68-78. doi:10.1016/j.jacep.2023.09.004

BibTeX
@article{Weiss2024,
  author = {Weiss, Raul and Osorio, Jose and Nair, Devi and Aguinaga, Luis and Arabia, Luis and Alcivar, Diego and Al-Ahmad, Amin and Tomassoni, Gery and Kahaly, Omar and Mehta, Rohit and Ward, Chad and Holmes, Benjamin and Patel, Dilesh and Killu, Ammar M and Munger, Thomas and Essandoh, Michael and Houmsse, Mahmoud and Rajendra, Anil and Morales, Gustavo and Hummel, John D and Balasubramanian, Gokulakrishan and Daoud, Emile G},
  title = {EsophAguS Deviation During RadiofrequencY Ablation of Atrial Fibrillation},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  volume = {10},
  number = {1},
  pages = {68--78},
  doi = {10.1016/j.jacep.2023.09.004}
}
Kostenlos starten →